BR112014025519B1 - Escherichia coli recombinante e método para produção de uma amida graxa - Google Patents
Escherichia coli recombinante e método para produção de uma amida graxa Download PDFInfo
- Publication number
 - BR112014025519B1 BR112014025519B1 BR112014025519-9A BR112014025519A BR112014025519B1 BR 112014025519 B1 BR112014025519 B1 BR 112014025519B1 BR 112014025519 A BR112014025519 A BR 112014025519A BR 112014025519 B1 BR112014025519 B1 BR 112014025519B1
 - Authority
 - BR
 - Brazil
 - Prior art keywords
 - fatty
 - polypeptide
 - coli
 - less
 - acyl
 - Prior art date
 
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 39
 - 241000588724 Escherichia coli Species 0.000 title claims description 48
 - 150000001408 amides Chemical class 0.000 title description 12
 - 150000002193 fatty amides Chemical class 0.000 claims abstract description 192
 - 244000005700 microbiome Species 0.000 claims abstract description 106
 - 238000000034 method Methods 0.000 claims abstract description 72
 - OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 61
 - -1 acyl thioester Chemical class 0.000 claims abstract description 61
 - 229910052799 carbon Inorganic materials 0.000 claims abstract description 61
 - 238000006243 chemical reaction Methods 0.000 claims abstract description 26
 - 238000012258 culturing Methods 0.000 claims abstract description 6
 - 108090000765 processed proteins & peptides Proteins 0.000 claims description 128
 - 102000004196 processed proteins & peptides Human genes 0.000 claims description 128
 - 229920001184 polypeptide Polymers 0.000 claims description 127
 - 108090000623 proteins and genes Proteins 0.000 claims description 77
 - 150000007523 nucleic acids Chemical group 0.000 claims description 75
 - 108091028043 Nucleic acid sequence Proteins 0.000 claims description 61
 - 235000014113 dietary fatty acids Nutrition 0.000 claims description 60
 - 229930195729 fatty acid Natural products 0.000 claims description 60
 - 239000000194 fatty acid Substances 0.000 claims description 60
 - 150000004665 fatty acids Chemical class 0.000 claims description 56
 - 230000014509 gene expression Effects 0.000 claims description 55
 - 150000003141 primary amines Chemical class 0.000 claims description 45
 - 101150087812 tesA gene Proteins 0.000 claims description 40
 - 108020002982 thioesterase Proteins 0.000 claims description 24
 - 102000005488 Thioesterase Human genes 0.000 claims description 23
 - 101150071111 FADD gene Proteins 0.000 claims description 22
 - VWGZHNDNCJLJRW-UHFFFAOYSA-N n-(4-aminobutyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCCCN VWGZHNDNCJLJRW-UHFFFAOYSA-N 0.000 claims description 20
 - 239000000758 substrate Substances 0.000 claims description 20
 - KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 16
 - 230000001851 biosynthetic effect Effects 0.000 claims description 14
 - 150000001720 carbohydrates Chemical class 0.000 claims description 12
 - 102000004169 proteins and genes Human genes 0.000 claims description 12
 - IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 claims description 11
 - 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
 - 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 9
 - 150000002185 fatty acyl-CoAs Chemical class 0.000 claims description 9
 - 239000005700 Putrescine Substances 0.000 claims description 8
 - HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 claims description 8
 - FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 6
 - HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims description 5
 - 235000014469 Bacillus subtilis Nutrition 0.000 claims description 5
 - 239000001963 growth medium Substances 0.000 claims description 5
 - ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 claims description 4
 - FAXDZWQIWUSWJH-UHFFFAOYSA-N 3-methoxypropan-1-amine Chemical compound COCCCN FAXDZWQIWUSWJH-UHFFFAOYSA-N 0.000 claims description 4
 - 241000588625 Acinetobacter sp. Species 0.000 claims description 4
 - 241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 claims description 4
 - WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 claims description 4
 - MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 4
 - LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 claims description 4
 - 241000423334 Bacillus halodurans C-125 Species 0.000 claims description 3
 - 244000063299 Bacillus subtilis Species 0.000 claims description 3
 - 101100127701 Bacillus subtilis (strain 168) lcfB gene Proteins 0.000 claims description 3
 - 101100502354 Escherichia coli (strain K12) fadK gene Proteins 0.000 claims description 3
 - 241001522878 Escherichia coli B Species 0.000 claims description 3
 - 241000644323 Escherichia coli C Species 0.000 claims description 3
 - 241000901842 Escherichia coli W Species 0.000 claims description 3
 - 241001240958 Pseudomonas aeruginosa PAO1 Species 0.000 claims description 3
 - 241000190950 Rhodopseudomonas palustris Species 0.000 claims description 3
 - 101150077217 yhfL gene Proteins 0.000 claims description 3
 - KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 claims description 2
 - 101100388296 Arabidopsis thaliana DTX51 gene Proteins 0.000 claims description 2
 - 241000589519 Comamonas Species 0.000 claims description 2
 - 241000606768 Haemophilus influenzae Species 0.000 claims description 2
 - 241000589771 Ralstonia solanacearum Species 0.000 claims description 2
 - 101100215626 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADP1 gene Proteins 0.000 claims description 2
 - 241000838225 Stenotrophomonas maltophilia R551-3 Species 0.000 claims description 2
 - 101150026728 tesB gene Proteins 0.000 claims description 2
 - 229960003604 testosterone Drugs 0.000 claims description 2
 - 101100127693 Bacillus subtilis (strain 168) lcfA gene Proteins 0.000 claims 1
 - 241001209206 Pseudomonas fluorescens Pf0-1 Species 0.000 claims 1
 - 102000004190 Enzymes Human genes 0.000 abstract description 28
 - 108090000790 Enzymes Proteins 0.000 abstract description 28
 - 125000002924 primary amino group Chemical class [H]N([H])* 0.000 abstract 1
 - 210000004027 cell Anatomy 0.000 description 127
 - 239000000203 mixture Substances 0.000 description 69
 - 238000004140 cleaning Methods 0.000 description 41
 - 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 34
 - 239000013612 plasmid Substances 0.000 description 34
 - 239000000047 product Substances 0.000 description 34
 - HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 31
 - XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
 - 125000003275 alpha amino acid group Chemical group 0.000 description 26
 - HXYVTAGFYLMHSO-UHFFFAOYSA-N palmitoyl ethanolamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCO HXYVTAGFYLMHSO-UHFFFAOYSA-N 0.000 description 26
 - 239000013598 vector Substances 0.000 description 22
 - 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 19
 - 239000000463 material Substances 0.000 description 18
 - HBMSIPLIFIVUKZ-UHFFFAOYSA-N Palmitinsaeure-propylamid Natural products CCCCCCCCCCCCCCCC(=O)NCCC HBMSIPLIFIVUKZ-UHFFFAOYSA-N 0.000 description 17
 - WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
 - 239000008103 glucose Substances 0.000 description 16
 - 108091033319 polynucleotide Proteins 0.000 description 16
 - 102000040430 polynucleotide Human genes 0.000 description 16
 - 239000002157 polynucleotide Substances 0.000 description 16
 - WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 15
 - 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
 - 239000003599 detergent Substances 0.000 description 14
 - 201000010099 disease Diseases 0.000 description 14
 - 239000002609 medium Substances 0.000 description 14
 - 102000039446 nucleic acids Human genes 0.000 description 14
 - 108020004707 nucleic acids Proteins 0.000 description 14
 - 239000013604 expression vector Substances 0.000 description 13
 - PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
 - 235000001014 amino acid Nutrition 0.000 description 12
 - 238000000855 fermentation Methods 0.000 description 12
 - 230000004151 fermentation Effects 0.000 description 12
 - 230000001965 increasing effect Effects 0.000 description 12
 - 239000004094 surface-active agent Substances 0.000 description 12
 - 239000002028 Biomass Substances 0.000 description 11
 - 241000196324 Embryophyta Species 0.000 description 11
 - 125000000217 alkyl group Chemical group 0.000 description 11
 - 150000001875 compounds Chemical class 0.000 description 11
 - MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 10
 - CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
 - MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 10
 - 229940024606 amino acid Drugs 0.000 description 10
 - 230000002238 attenuated effect Effects 0.000 description 10
 - 235000014633 carbohydrates Nutrition 0.000 description 10
 - 235000018102 proteins Nutrition 0.000 description 10
 - 230000001105 regulatory effect Effects 0.000 description 10
 - 150000007970 thio esters Chemical class 0.000 description 10
 - 108020004414 DNA Proteins 0.000 description 9
 - 230000015572 biosynthetic process Effects 0.000 description 9
 - 101150061398 fabR gene Proteins 0.000 description 9
 - 125000004404 heteroalkyl group Chemical group 0.000 description 9
 - 239000007788 liquid Substances 0.000 description 9
 - 230000002018 overexpression Effects 0.000 description 9
 - 239000003795 chemical substances by application Substances 0.000 description 8
 - 239000012634 fragment Substances 0.000 description 8
 - 230000014759 maintenance of location Effects 0.000 description 8
 - 235000021122 unsaturated fatty acids Nutrition 0.000 description 8
 - IWBKAHRYLFPHRI-UHFFFAOYSA-N N-(4-amino-2-hydroxybutyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCC(O)CCN IWBKAHRYLFPHRI-UHFFFAOYSA-N 0.000 description 7
 - 101710198056 Serine decarboxylase Proteins 0.000 description 7
 - 150000001413 amino acids Chemical class 0.000 description 7
 - LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 description 7
 - 230000000694 effects Effects 0.000 description 7
 - 238000001727 in vivo Methods 0.000 description 7
 - 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 7
 - 235000015097 nutrients Nutrition 0.000 description 7
 - BOWVQLFMWHZBEF-KTKRTIGZSA-N oleoyl ethanolamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCO BOWVQLFMWHZBEF-KTKRTIGZSA-N 0.000 description 7
 - 150000002894 organic compounds Chemical class 0.000 description 7
 - 229920000642 polymer Polymers 0.000 description 7
 - 239000007787 solid Substances 0.000 description 7
 - 150000004670 unsaturated fatty acids Chemical class 0.000 description 7
 - 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 6
 - 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 6
 - 102100032252 Antizyme inhibitor 2 Human genes 0.000 description 6
 - 241000193830 Bacillus <bacterium> Species 0.000 description 6
 - 241000894006 Bacteria Species 0.000 description 6
 - 108010018763 Biotin carboxylase Proteins 0.000 description 6
 - 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 description 6
 - 241001465754 Metazoa Species 0.000 description 6
 - XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 6
 - 208000002193 Pain Diseases 0.000 description 6
 - ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 6
 - 125000003342 alkenyl group Chemical group 0.000 description 6
 - 238000004458 analytical method Methods 0.000 description 6
 - LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 description 6
 - 230000001580 bacterial effect Effects 0.000 description 6
 - 125000004432 carbon atom Chemical group C* 0.000 description 6
 - 238000010367 cloning Methods 0.000 description 6
 - 230000029087 digestion Effects 0.000 description 6
 - 239000002816 fuel additive Substances 0.000 description 6
 - 230000012010 growth Effects 0.000 description 6
 - 239000000543 intermediate Substances 0.000 description 6
 - 150000002632 lipids Chemical class 0.000 description 6
 - 239000003921 oil Substances 0.000 description 6
 - 235000019198 oils Nutrition 0.000 description 6
 - 239000003208 petroleum Substances 0.000 description 6
 - 239000008194 pharmaceutical composition Substances 0.000 description 6
 - 239000002243 precursor Substances 0.000 description 6
 - 239000002994 raw material Substances 0.000 description 6
 - 230000009467 reduction Effects 0.000 description 6
 - 238000004448 titration Methods 0.000 description 6
 - 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
 - 108700016258 Agmatinases Proteins 0.000 description 5
 - 241000233866 Fungi Species 0.000 description 5
 - XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 5
 - 102000011229 agmatinase Human genes 0.000 description 5
 - 230000008827 biological function Effects 0.000 description 5
 - 229910002092 carbon dioxide Inorganic materials 0.000 description 5
 - 238000010276 construction Methods 0.000 description 5
 - 238000005516 engineering process Methods 0.000 description 5
 - 238000003780 insertion Methods 0.000 description 5
 - 230000037431 insertion Effects 0.000 description 5
 - 230000008569 process Effects 0.000 description 5
 - 230000010076 replication Effects 0.000 description 5
 - 239000002904 solvent Substances 0.000 description 5
 - 241000894007 species Species 0.000 description 5
 - 239000000126 substance Substances 0.000 description 5
 - 230000002103 transcriptional effect Effects 0.000 description 5
 - 241000186063 Arthrobacter Species 0.000 description 4
 - IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
 - IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
 - JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 4
 - 206010061218 Inflammation Diseases 0.000 description 4
 - 239000006137 Luria-Bertani broth Substances 0.000 description 4
 - 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
 - 241000235015 Yarrowia lipolytica Species 0.000 description 4
 - 240000008042 Zea mays Species 0.000 description 4
 - 239000000654 additive Substances 0.000 description 4
 - 230000000996 additive effect Effects 0.000 description 4
 - 125000001931 aliphatic group Chemical group 0.000 description 4
 - 230000009435 amidation Effects 0.000 description 4
 - 238000007112 amidation reaction Methods 0.000 description 4
 - 125000000539 amino acid group Chemical group 0.000 description 4
 - 239000003242 anti bacterial agent Substances 0.000 description 4
 - PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
 - 238000002869 basic local alignment search tool Methods 0.000 description 4
 - 230000008901 benefit Effects 0.000 description 4
 - SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
 - 235000010633 broth Nutrition 0.000 description 4
 - 239000001569 carbon dioxide Substances 0.000 description 4
 - 210000000349 chromosome Anatomy 0.000 description 4
 - 101150016526 fadE gene Proteins 0.000 description 4
 - 235000011187 glycerol Nutrition 0.000 description 4
 - 239000004519 grease Substances 0.000 description 4
 - 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
 - 230000001939 inductive effect Effects 0.000 description 4
 - 230000004054 inflammatory process Effects 0.000 description 4
 - BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
 - 239000006210 lotion Substances 0.000 description 4
 - 229910052757 nitrogen Inorganic materials 0.000 description 4
 - 229910052760 oxygen Inorganic materials 0.000 description 4
 - 230000036407 pain Effects 0.000 description 4
 - 230000037361 pathway Effects 0.000 description 4
 - 102000005962 receptors Human genes 0.000 description 4
 - 108020003175 receptors Proteins 0.000 description 4
 - 239000002453 shampoo Substances 0.000 description 4
 - 125000001424 substituent group Chemical group 0.000 description 4
 - 102000002735 Acyl-CoA Dehydrogenase Human genes 0.000 description 3
 - 108010001058 Acyl-CoA Dehydrogenase Proteins 0.000 description 3
 - 239000004475 Arginine Substances 0.000 description 3
 - 229920000324 Cellulosome Polymers 0.000 description 3
 - 240000006262 Cuphea hookeriana Species 0.000 description 3
 - LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
 - OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
 - 102000003855 L-lactate dehydrogenase Human genes 0.000 description 3
 - 108700023483 L-lactate dehydrogenases Proteins 0.000 description 3
 - 102100037611 Lysophospholipase Human genes 0.000 description 3
 - LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 3
 - OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
 - 101710116435 Outer membrane protein Proteins 0.000 description 3
 - 241000196250 Prototheca Species 0.000 description 3
 - 241000192560 Synechococcus sp. Species 0.000 description 3
 - 101100119785 Vibrio anguillarum (strain ATCC 68554 / 775) fatB gene Proteins 0.000 description 3
 - 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
 - 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
 - 101150008263 accD gene Proteins 0.000 description 3
 - 229940088710 antibiotic agent Drugs 0.000 description 3
 - 239000003963 antioxidant agent Substances 0.000 description 3
 - PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
 - ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
 - 230000006696 biosynthetic metabolic pathway Effects 0.000 description 3
 - 238000004113 cell culture Methods 0.000 description 3
 - 230000010261 cell growth Effects 0.000 description 3
 - 230000001413 cellular effect Effects 0.000 description 3
 - 239000001913 cellulose Substances 0.000 description 3
 - 229920002678 cellulose Polymers 0.000 description 3
 - 235000010980 cellulose Nutrition 0.000 description 3
 - 210000000166 cellulosome Anatomy 0.000 description 3
 - MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
 - 239000000356 contaminant Substances 0.000 description 3
 - 235000005822 corn Nutrition 0.000 description 3
 - 239000002537 cosmetic Substances 0.000 description 3
 - 239000003814 drug Substances 0.000 description 3
 - 239000000975 dye Substances 0.000 description 3
 - 239000003623 enhancer Substances 0.000 description 3
 - 230000007613 environmental effect Effects 0.000 description 3
 - 230000007717 exclusion Effects 0.000 description 3
 - 239000003925 fat Substances 0.000 description 3
 - 235000019197 fats Nutrition 0.000 description 3
 - 239000000945 filler Substances 0.000 description 3
 - 239000006260 foam Substances 0.000 description 3
 - 108010008221 formate C-acetyltransferase Proteins 0.000 description 3
 - 230000006870 function Effects 0.000 description 3
 - 239000000499 gel Substances 0.000 description 3
 - 125000005842 heteroatom Chemical group 0.000 description 3
 - 239000004615 ingredient Substances 0.000 description 3
 - 150000002500 ions Chemical class 0.000 description 3
 - 238000002955 isolation Methods 0.000 description 3
 - LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 3
 - 238000004949 mass spectrometry Methods 0.000 description 3
 - 230000037353 metabolic pathway Effects 0.000 description 3
 - 230000004048 modification Effects 0.000 description 3
 - 238000012986 modification Methods 0.000 description 3
 - BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
 - 239000002773 nucleotide Substances 0.000 description 3
 - 125000003729 nucleotide group Chemical group 0.000 description 3
 - 239000002304 perfume Substances 0.000 description 3
 - 150000008104 phosphatidylethanolamines Chemical class 0.000 description 3
 - 238000000746 purification Methods 0.000 description 3
 - 239000007320 rich medium Substances 0.000 description 3
 - 150000003839 salts Chemical class 0.000 description 3
 - 229920006395 saturated elastomer Polymers 0.000 description 3
 - 238000003786 synthesis reaction Methods 0.000 description 3
 - 239000003826 tablet Substances 0.000 description 3
 - 238000012360 testing method Methods 0.000 description 3
 - 238000001890 transfection Methods 0.000 description 3
 - GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 3
 - 239000002699 waste material Substances 0.000 description 3
 - 239000002023 wood Substances 0.000 description 3
 - 241000589291 Acinetobacter Species 0.000 description 2
 - QYPPJABKJHAVHS-UHFFFAOYSA-N Agmatine Natural products NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 description 2
 - 241000219195 Arabidopsis thaliana Species 0.000 description 2
 - 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 2
 - 101100350224 Bacillus subtilis (strain 168) pdhB gene Proteins 0.000 description 2
 - 244000025254 Cannabis sativa Species 0.000 description 2
 - 102000014914 Carrier Proteins Human genes 0.000 description 2
 - 108010078791 Carrier Proteins Proteins 0.000 description 2
 - 101100236536 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) glcB gene Proteins 0.000 description 2
 - 241000195493 Cryptophyta Species 0.000 description 2
 - JDMUPRLRUUMCTL-VIFPVBQESA-N D-pantetheine 4'-phosphate Chemical compound OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS JDMUPRLRUUMCTL-VIFPVBQESA-N 0.000 description 2
 - SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
 - 102000012410 DNA Ligases Human genes 0.000 description 2
 - 108010061982 DNA Ligases Proteins 0.000 description 2
 - 101100390711 Escherichia coli (strain K12) fhuA gene Proteins 0.000 description 2
 - 101100447155 Escherichia coli (strain K12) fre gene Proteins 0.000 description 2
 - 241000223198 Humicola Species 0.000 description 2
 - 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
 - 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 2
 - QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
 - 241000192041 Micrococcus Species 0.000 description 2
 - 241000235395 Mucor Species 0.000 description 2
 - 241000228143 Penicillium Species 0.000 description 2
 - 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 2
 - 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 2
 - 241001074118 Prototheca moriformis Species 0.000 description 2
 - 241001597169 Prototheca stagnorum Species 0.000 description 2
 - 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 2
 - 101100406344 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceF gene Proteins 0.000 description 2
 - 108020004511 Recombinant DNA Proteins 0.000 description 2
 - 102000009661 Repressor Proteins Human genes 0.000 description 2
 - 108010034634 Repressor Proteins Proteins 0.000 description 2
 - 240000000111 Saccharum officinarum Species 0.000 description 2
 - 235000007201 Saccharum officinarum Nutrition 0.000 description 2
 - 238000012300 Sequence Analysis Methods 0.000 description 2
 - 229920002472 Starch Polymers 0.000 description 2
 - 241000122973 Stenotrophomonas maltophilia Species 0.000 description 2
 - 241000187747 Streptomyces Species 0.000 description 2
 - 241000187432 Streptomyces coelicolor Species 0.000 description 2
 - 229930006000 Sucrose Natural products 0.000 description 2
 - CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
 - AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
 - 239000004473 Threonine Substances 0.000 description 2
 - 241000607598 Vibrio Species 0.000 description 2
 - 238000004760 accelerator mass spectrometry Methods 0.000 description 2
 - 101150094017 aceA gene Proteins 0.000 description 2
 - 101150036393 aceB gene Proteins 0.000 description 2
 - 101150001446 aceK gene Proteins 0.000 description 2
 - 230000002378 acidificating effect Effects 0.000 description 2
 - 230000009471 action Effects 0.000 description 2
 - 125000002252 acyl group Chemical group 0.000 description 2
 - QYPPJABKJHAVHS-UHFFFAOYSA-P agmatinium(2+) Chemical compound NC(=[NH2+])NCCCC[NH3+] QYPPJABKJHAVHS-UHFFFAOYSA-P 0.000 description 2
 - 239000000556 agonist Substances 0.000 description 2
 - 235000004279 alanine Nutrition 0.000 description 2
 - 150000001298 alcohols Chemical class 0.000 description 2
 - 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
 - 125000003368 amide group Chemical group 0.000 description 2
 - AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
 - 229960000723 ampicillin Drugs 0.000 description 2
 - 239000002518 antifoaming agent Substances 0.000 description 2
 - 230000003078 antioxidant effect Effects 0.000 description 2
 - SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 2
 - 125000003118 aryl group Chemical group 0.000 description 2
 - 239000012298 atmosphere Substances 0.000 description 2
 - QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
 - 101150070136 axeA gene Proteins 0.000 description 2
 - 239000002199 base oil Substances 0.000 description 2
 - 230000027455 binding Effects 0.000 description 2
 - 230000003115 biocidal effect Effects 0.000 description 2
 - 239000012620 biological material Substances 0.000 description 2
 - 230000033228 biological regulation Effects 0.000 description 2
 - OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
 - 230000036772 blood pressure Effects 0.000 description 2
 - 230000037396 body weight Effects 0.000 description 2
 - 229930003827 cannabinoid Natural products 0.000 description 2
 - 239000003557 cannabinoid Substances 0.000 description 2
 - 230000003197 catalytic effect Effects 0.000 description 2
 - 230000003915 cell function Effects 0.000 description 2
 - 239000002738 chelating agent Substances 0.000 description 2
 - 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
 - 239000010779 crude oil Substances 0.000 description 2
 - 125000004122 cyclic group Chemical group 0.000 description 2
 - 238000006114 decarboxylation reaction Methods 0.000 description 2
 - 238000012217 deletion Methods 0.000 description 2
 - 230000037430 deletion Effects 0.000 description 2
 - 238000001212 derivatisation Methods 0.000 description 2
 - VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 2
 - 150000002016 disaccharides Chemical class 0.000 description 2
 - 238000004851 dishwashing Methods 0.000 description 2
 - 239000002270 dispersing agent Substances 0.000 description 2
 - 238000005553 drilling Methods 0.000 description 2
 - 238000004520 electroporation Methods 0.000 description 2
 - 239000000839 emulsion Substances 0.000 description 2
 - 230000002255 enzymatic effect Effects 0.000 description 2
 - 210000003527 eukaryotic cell Anatomy 0.000 description 2
 - 101150015067 fabB gene Proteins 0.000 description 2
 - 101150004992 fadA gene Proteins 0.000 description 2
 - 101150069125 fadB gene Proteins 0.000 description 2
 - 101150027774 fadI gene Proteins 0.000 description 2
 - 101150092019 fadJ gene Proteins 0.000 description 2
 - 101150094039 fadL gene Proteins 0.000 description 2
 - 101150039130 fadM gene Proteins 0.000 description 2
 - 101150115959 fadR gene Proteins 0.000 description 2
 - 230000004129 fatty acid metabolism Effects 0.000 description 2
 - 239000004088 foaming agent Substances 0.000 description 2
 - 230000037406 food intake Effects 0.000 description 2
 - 235000012631 food intake Nutrition 0.000 description 2
 - 239000000446 fuel Substances 0.000 description 2
 - 238000004128 high performance liquid chromatography Methods 0.000 description 2
 - 229930195733 hydrocarbon Natural products 0.000 description 2
 - 150000002430 hydrocarbons Chemical class 0.000 description 2
 - 208000027866 inflammatory disease Diseases 0.000 description 2
 - 238000001802 infusion Methods 0.000 description 2
 - 239000011256 inorganic filler Substances 0.000 description 2
 - 229910003475 inorganic filler Inorganic materials 0.000 description 2
 - 230000003834 intracellular effect Effects 0.000 description 2
 - 230000004410 intraocular pressure Effects 0.000 description 2
 - 238000001948 isotopic labelling Methods 0.000 description 2
 - 238000004811 liquid chromatography Methods 0.000 description 2
 - 239000003550 marker Substances 0.000 description 2
 - 230000002503 metabolic effect Effects 0.000 description 2
 - 230000004060 metabolic process Effects 0.000 description 2
 - 229930182817 methionine Natural products 0.000 description 2
 - 239000003607 modifier Substances 0.000 description 2
 - 150000002772 monosaccharides Chemical class 0.000 description 2
 - 201000006417 multiple sclerosis Diseases 0.000 description 2
 - 230000004112 neuroprotection Effects 0.000 description 2
 - 239000012074 organic phase Substances 0.000 description 2
 - 239000001301 oxygen Substances 0.000 description 2
 - 239000003002 pH adjusting agent Substances 0.000 description 2
 - 239000002245 particle Substances 0.000 description 2
 - 238000010419 pet care Methods 0.000 description 2
 - 239000011846 petroleum-based material Substances 0.000 description 2
 - 239000013520 petroleum-based product Substances 0.000 description 2
 - 229920001282 polysaccharide Polymers 0.000 description 2
 - 239000005017 polysaccharide Substances 0.000 description 2
 - 150000004804 polysaccharides Chemical class 0.000 description 2
 - 229920001296 polysiloxane Polymers 0.000 description 2
 - 239000000843 powder Substances 0.000 description 2
 - 238000002360 preparation method Methods 0.000 description 2
 - 239000003755 preservative agent Substances 0.000 description 2
 - 210000001236 prokaryotic cell Anatomy 0.000 description 2
 - 239000012925 reference material Substances 0.000 description 2
 - 238000000926 separation method Methods 0.000 description 2
 - 229910052710 silicon Inorganic materials 0.000 description 2
 - 150000003384 small molecules Chemical class 0.000 description 2
 - 230000006641 stabilisation Effects 0.000 description 2
 - 238000011105 stabilization Methods 0.000 description 2
 - 239000008107 starch Substances 0.000 description 2
 - 235000019698 starch Nutrition 0.000 description 2
 - 239000007858 starting material Substances 0.000 description 2
 - 238000006467 substitution reaction Methods 0.000 description 2
 - 239000005720 sucrose Substances 0.000 description 2
 - 229910052717 sulfur Inorganic materials 0.000 description 2
 - 208000024891 symptom Diseases 0.000 description 2
 - 229940124597 therapeutic agent Drugs 0.000 description 2
 - 238000004809 thin layer chromatography Methods 0.000 description 2
 - 125000003396 thiol group Chemical group [H]S* 0.000 description 2
 - 230000009466 transformation Effects 0.000 description 2
 - 230000011637 translesion synthesis Effects 0.000 description 2
 - 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
 - 101150046028 umuD gene Proteins 0.000 description 2
 - 238000011144 upstream manufacturing Methods 0.000 description 2
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
 - ISJHUKIGBLJDNA-DKWTVANSSA-N (2s)-2-amino-3-phosphonooxypropanoic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)[C@@H](N)COP(O)(O)=O ISJHUKIGBLJDNA-DKWTVANSSA-N 0.000 description 1
 - PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
 - ASWBNKHCZGQVJV-HSZRJFAPSA-N 1-hexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-HSZRJFAPSA-N 0.000 description 1
 - OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
 - OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
 - 241000023308 Acca Species 0.000 description 1
 - 241000186361 Actinobacteria <class> Species 0.000 description 1
 - 229920001817 Agar Polymers 0.000 description 1
 - 208000024827 Alzheimer disease Diseases 0.000 description 1
 - MVVPIAAVGAWJNQ-DOFZRALJSA-N Arachidonoyl dopamine Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCC1=CC=C(O)C(O)=C1 MVVPIAAVGAWJNQ-DOFZRALJSA-N 0.000 description 1
 - DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
 - 241000228212 Aspergillus Species 0.000 description 1
 - 241001513093 Aspergillus awamori Species 0.000 description 1
 - 241000892910 Aspergillus foetidus Species 0.000 description 1
 - 241001225321 Aspergillus fumigatus Species 0.000 description 1
 - 241000351920 Aspergillus nidulans Species 0.000 description 1
 - 241000228245 Aspergillus niger Species 0.000 description 1
 - 240000006439 Aspergillus oryzae Species 0.000 description 1
 - 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
 - 208000023275 Autoimmune disease Diseases 0.000 description 1
 - 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
 - 241000193752 Bacillus circulans Species 0.000 description 1
 - 241001328122 Bacillus clausii Species 0.000 description 1
 - 241000193749 Bacillus coagulans Species 0.000 description 1
 - 241000193422 Bacillus lentus Species 0.000 description 1
 - 241000194107 Bacillus megaterium Species 0.000 description 1
 - 241000194103 Bacillus pumilus Species 0.000 description 1
 - 101100378010 Bacillus subtilis (strain 168) accC1 gene Proteins 0.000 description 1
 - 101100322122 Bacillus subtilis (strain 168) accC2 gene Proteins 0.000 description 1
 - 101100095222 Bacillus subtilis (strain 168) sdaAB gene Proteins 0.000 description 1
 - 241000193388 Bacillus thuringiensis Species 0.000 description 1
 - 108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 1
 - 241001536324 Botryococcus Species 0.000 description 1
 - 241001536303 Botryococcus braunii Species 0.000 description 1
 - 241000193764 Brevibacillus brevis Species 0.000 description 1
 - 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 1
 - 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 1
 - DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
 - OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
 - UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
 - 239000004215 Carbon black (E152) Substances 0.000 description 1
 - 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
 - 241000191368 Chlorobi Species 0.000 description 1
 - 241001142109 Chloroflexi Species 0.000 description 1
 - 241000190834 Chromatiaceae Species 0.000 description 1
 - 208000000094 Chronic Pain Diseases 0.000 description 1
 - 241000123346 Chrysosporium Species 0.000 description 1
 - 241000193403 Clostridium Species 0.000 description 1
 - 108020004705 Codon Proteins 0.000 description 1
 - 241000186216 Corynebacterium Species 0.000 description 1
 - 101100263205 Coxiella burnetii (strain RSA 493 / Nine Mile phase I) uspA2 gene Proteins 0.000 description 1
 - 208000011231 Crohn disease Diseases 0.000 description 1
 - 244000303965 Cyamopsis psoralioides Species 0.000 description 1
 - 241000192700 Cyanobacteria Species 0.000 description 1
 - 241001464430 Cyanobacterium Species 0.000 description 1
 - 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
 - WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
 - 102000053602 DNA Human genes 0.000 description 1
 - 230000012746 DNA damage checkpoint Effects 0.000 description 1
 - 230000004568 DNA-binding Effects 0.000 description 1
 - 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
 - 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
 - 208000001840 Dandruff Diseases 0.000 description 1
 - 229920002307 Dextran Polymers 0.000 description 1
 - 241000588722 Escherichia Species 0.000 description 1
 - 241000701988 Escherichia virus T5 Species 0.000 description 1
 - 108010077487 Ethanolamine ammonia-lyase Proteins 0.000 description 1
 - VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
 - 239000005977 Ethylene Substances 0.000 description 1
 - 241000206602 Eukaryota Species 0.000 description 1
 - 229930091371 Fructose Natural products 0.000 description 1
 - RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
 - 239000005715 Fructose Substances 0.000 description 1
 - 230000005526 G1 to G0 transition Effects 0.000 description 1
 - 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
 - 208000010412 Glaucoma Diseases 0.000 description 1
 - WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
 - 244000068988 Glycine max Species 0.000 description 1
 - 235000010469 Glycine max Nutrition 0.000 description 1
 - 101100135734 Haloferax mediterranei (strain ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4) pccB gene Proteins 0.000 description 1
 - 244000020551 Helianthus annuus Species 0.000 description 1
 - 235000003222 Helianthus annuus Nutrition 0.000 description 1
 - 241001480714 Humicola insolens Species 0.000 description 1
 - 208000023105 Huntington disease Diseases 0.000 description 1
 - 206010020772 Hypertension Diseases 0.000 description 1
 - 241000235649 Kluyveromyces Species 0.000 description 1
 - 241000235058 Komagataella pastoris Species 0.000 description 1
 - DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
 - CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
 - WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
 - ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
 - AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
 - ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
 - FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
 - COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
 - OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
 - KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
 - JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
 - 241000186660 Lactobacillus Species 0.000 description 1
 - ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
 - 235000019738 Limestone Nutrition 0.000 description 1
 - 241001625930 Luria Species 0.000 description 1
 - 239000006142 Luria-Bertani Agar Substances 0.000 description 1
 - KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
 - 239000004472 Lysine Substances 0.000 description 1
 - GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
 - 241000226677 Myceliophthora Species 0.000 description 1
 - 208000007201 Myocardial reperfusion injury Diseases 0.000 description 1
 - 239000006057 Non-nutritive feed additive Substances 0.000 description 1
 - 229910003849 O-Si Inorganic materials 0.000 description 1
 - 229910003872 O—Si Inorganic materials 0.000 description 1
 - 241000209117 Panicum Species 0.000 description 1
 - 235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 1
 - 235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 1
 - 208000018737 Parkinson disease Diseases 0.000 description 1
 - 241000222385 Phanerochaete Species 0.000 description 1
 - 102000011025 Phosphoglycerate Mutase Human genes 0.000 description 1
 - 108010038555 Phosphoglycerate dehydrogenase Proteins 0.000 description 1
 - 102000011420 Phospholipase D Human genes 0.000 description 1
 - 108090000553 Phospholipase D Proteins 0.000 description 1
 - 241000235648 Pichia Species 0.000 description 1
 - 241000222350 Pleurotus Species 0.000 description 1
 - 241000209504 Poaceae Species 0.000 description 1
 - 241000196248 Prototheca zopfii Species 0.000 description 1
 - 241000589516 Pseudomonas Species 0.000 description 1
 - 241000235402 Rhizomucor Species 0.000 description 1
 - 241000235403 Rhizomucor miehei Species 0.000 description 1
 - 241000191023 Rhodobacter capsulatus Species 0.000 description 1
 - 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
 - 241001524101 Rhodococcus opacus Species 0.000 description 1
 - 241000190932 Rhodopseudomonas Species 0.000 description 1
 - 241000131970 Rhodospirillaceae Species 0.000 description 1
 - 241000190984 Rhodospirillum rubrum Species 0.000 description 1
 - 241000223252 Rhodotorula Species 0.000 description 1
 - 108091028664 Ribonucleotide Proteins 0.000 description 1
 - 241000235070 Saccharomyces Species 0.000 description 1
 - 241001466077 Salina Species 0.000 description 1
 - 241000235346 Schizosaccharomyces Species 0.000 description 1
 - 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
 - 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
 - BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
 - PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
 - 108091081024 Start codon Proteins 0.000 description 1
 - 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 description 1
 - 241000187398 Streptomyces lividans Species 0.000 description 1
 - 208000006011 Stroke Diseases 0.000 description 1
 - 241000192707 Synechococcus Species 0.000 description 1
 - 241000192581 Synechocystis sp. Species 0.000 description 1
 - 108010025083 TRPV1 receptor Proteins 0.000 description 1
 - 241000222354 Trametes Species 0.000 description 1
 - 108091023040 Transcription factor Proteins 0.000 description 1
 - 102000040945 Transcription factor Human genes 0.000 description 1
 - 108090000992 Transferases Proteins 0.000 description 1
 - 102000004357 Transferases Human genes 0.000 description 1
 - 208000030886 Traumatic Brain injury Diseases 0.000 description 1
 - 241000223259 Trichoderma Species 0.000 description 1
 - 241000378866 Trichoderma koningii Species 0.000 description 1
 - 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
 - 241000499912 Trichoderma reesei Species 0.000 description 1
 - 241000223261 Trichoderma viride Species 0.000 description 1
 - 239000007983 Tris buffer Substances 0.000 description 1
 - DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
 - KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
 - 241000235013 Yarrowia Species 0.000 description 1
 - 235000007244 Zea mays Nutrition 0.000 description 1
 - 241000588902 Zymomonas mobilis Species 0.000 description 1
 - 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 description 1
 - 239000003082 abrasive agent Substances 0.000 description 1
 - 239000006096 absorbing agent Substances 0.000 description 1
 - 101150046124 accA gene Proteins 0.000 description 1
 - 101150013885 accB gene Proteins 0.000 description 1
 - 101150070497 accC gene Proteins 0.000 description 1
 - 150000001242 acetic acid derivatives Chemical class 0.000 description 1
 - DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
 - 239000002253 acid Substances 0.000 description 1
 - 150000007513 acids Chemical class 0.000 description 1
 - 239000012190 activator Substances 0.000 description 1
 - 239000013543 active substance Substances 0.000 description 1
 - 230000001154 acute effect Effects 0.000 description 1
 - 208000005298 acute pain Diseases 0.000 description 1
 - 238000007792 addition Methods 0.000 description 1
 - 239000002671 adjuvant Substances 0.000 description 1
 - 238000005273 aeration Methods 0.000 description 1
 - 239000008272 agar Substances 0.000 description 1
 - 150000001299 aldehydes Chemical class 0.000 description 1
 - 239000003513 alkali Substances 0.000 description 1
 - 125000003545 alkoxy group Chemical group 0.000 description 1
 - 125000003282 alkyl amino group Chemical group 0.000 description 1
 - WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
 - 125000003277 amino group Chemical group 0.000 description 1
 - 125000004103 aminoalkyl group Chemical group 0.000 description 1
 - 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
 - 230000036592 analgesia Effects 0.000 description 1
 - 230000003110 anti-inflammatory effect Effects 0.000 description 1
 - 230000003502 anti-nociceptive effect Effects 0.000 description 1
 - 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
 - 230000006907 apoptotic process Effects 0.000 description 1
 - 125000003710 aryl alkyl group Chemical group 0.000 description 1
 - 235000009582 asparagine Nutrition 0.000 description 1
 - 229960001230 asparagine Drugs 0.000 description 1
 - 235000003704 aspartic acid Nutrition 0.000 description 1
 - 238000003556 assay Methods 0.000 description 1
 - 230000001651 autotrophic effect Effects 0.000 description 1
 - 229940054340 bacillus coagulans Drugs 0.000 description 1
 - 229940097012 bacillus thuringiensis Drugs 0.000 description 1
 - 230000009286 beneficial effect Effects 0.000 description 1
 - 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
 - OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
 - GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
 - 239000003139 biocide Substances 0.000 description 1
 - 239000002551 biofuel Substances 0.000 description 1
 - 230000004071 biological effect Effects 0.000 description 1
 - 239000007844 bleaching agent Substances 0.000 description 1
 - 230000007883 bronchodilation Effects 0.000 description 1
 - 239000006227 byproduct Substances 0.000 description 1
 - 229910052791 calcium Inorganic materials 0.000 description 1
 - 239000011575 calcium Substances 0.000 description 1
 - 239000001110 calcium chloride Substances 0.000 description 1
 - 229910001628 calcium chloride Inorganic materials 0.000 description 1
 - 239000001506 calcium phosphate Substances 0.000 description 1
 - 229910000389 calcium phosphate Inorganic materials 0.000 description 1
 - 235000011010 calcium phosphates Nutrition 0.000 description 1
 - 239000002775 capsule Substances 0.000 description 1
 - FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
 - 229960003669 carbenicillin Drugs 0.000 description 1
 - 150000001721 carbon Chemical group 0.000 description 1
 - 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
 - 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
 - 239000001768 carboxy methyl cellulose Substances 0.000 description 1
 - 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
 - 239000012159 carrier gas Substances 0.000 description 1
 - 230000015556 catabolic process Effects 0.000 description 1
 - 125000002091 cationic group Chemical group 0.000 description 1
 - 239000003093 cationic surfactant Substances 0.000 description 1
 - 239000006143 cell culture medium Substances 0.000 description 1
 - 210000003850 cellular structure Anatomy 0.000 description 1
 - 210000003169 central nervous system Anatomy 0.000 description 1
 - 239000000919 ceramic Substances 0.000 description 1
 - 238000012512 characterization method Methods 0.000 description 1
 - 239000007795 chemical reaction product Substances 0.000 description 1
 - 239000003153 chemical reaction reagent Substances 0.000 description 1
 - 239000003638 chemical reducing agent Substances 0.000 description 1
 - 150000001805 chlorine compounds Chemical class 0.000 description 1
 - 230000001684 chronic effect Effects 0.000 description 1
 - 239000004927 clay Chemical class 0.000 description 1
 - 238000000975 co-precipitation Methods 0.000 description 1
 - 239000003240 coconut oil Substances 0.000 description 1
 - 235000019864 coconut oil Nutrition 0.000 description 1
 - 239000005516 coenzyme A Substances 0.000 description 1
 - 229940093530 coenzyme a Drugs 0.000 description 1
 - 238000004590 computer program Methods 0.000 description 1
 - 239000012141 concentrate Substances 0.000 description 1
 - 230000003750 conditioning effect Effects 0.000 description 1
 - 238000012790 confirmation Methods 0.000 description 1
 - 230000001276 controlling effect Effects 0.000 description 1
 - 238000005260 corrosion Methods 0.000 description 1
 - 239000006071 cream Substances 0.000 description 1
 - 235000021438 curry Nutrition 0.000 description 1
 - 210000000805 cytoplasm Anatomy 0.000 description 1
 - 230000003247 decreasing effect Effects 0.000 description 1
 - 238000006731 degradation reaction Methods 0.000 description 1
 - 230000000593 degrading effect Effects 0.000 description 1
 - 239000005547 deoxyribonucleotide Substances 0.000 description 1
 - 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
 - 230000001419 dependent effect Effects 0.000 description 1
 - 238000009795 derivation Methods 0.000 description 1
 - 238000013461 design Methods 0.000 description 1
 - 238000010586 diagram Methods 0.000 description 1
 - 125000004663 dialkyl amino group Chemical group 0.000 description 1
 - 239000003085 diluting agent Substances 0.000 description 1
 - 238000010790 dilution Methods 0.000 description 1
 - 239000012895 dilution Substances 0.000 description 1
 - 208000035475 disorder Diseases 0.000 description 1
 - 238000009826 distribution Methods 0.000 description 1
 - 239000010791 domestic waste Substances 0.000 description 1
 - 239000003937 drug carrier Substances 0.000 description 1
 - 235000013399 edible fruits Nutrition 0.000 description 1
 - 239000003995 emulsifying agent Substances 0.000 description 1
 - 206010015037 epilepsy Diseases 0.000 description 1
 - 238000003810 ethyl acetate extraction Methods 0.000 description 1
 - 239000001761 ethyl methyl cellulose Substances 0.000 description 1
 - 239000000284 extract Substances 0.000 description 1
 - 239000004744 fabric Substances 0.000 description 1
 - 239000002979 fabric softener Substances 0.000 description 1
 - 230000004133 fatty acid degradation Effects 0.000 description 1
 - 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
 - 210000003608 fece Anatomy 0.000 description 1
 - 239000002921 fermentation waste Substances 0.000 description 1
 - 239000012530 fluid Substances 0.000 description 1
 - 235000013305 food Nutrition 0.000 description 1
 - 239000010794 food waste Substances 0.000 description 1
 - 238000009472 formulation Methods 0.000 description 1
 - 235000021588 free fatty acids Nutrition 0.000 description 1
 - FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
 - 229940107187 fructooligosaccharide Drugs 0.000 description 1
 - 230000002538 fungal effect Effects 0.000 description 1
 - 230000004927 fusion Effects 0.000 description 1
 - 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
 - 150000003271 galactooligosaccharides Chemical class 0.000 description 1
 - 229930182830 galactose Natural products 0.000 description 1
 - 239000007789 gas Substances 0.000 description 1
 - 238000012224 gene deletion Methods 0.000 description 1
 - 238000012226 gene silencing method Methods 0.000 description 1
 - 230000002070 germicidal effect Effects 0.000 description 1
 - 239000011521 glass Substances 0.000 description 1
 - 101150117187 glmS gene Proteins 0.000 description 1
 - 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
 - 235000013922 glutamic acid Nutrition 0.000 description 1
 - 239000004220 glutamic acid Substances 0.000 description 1
 - ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
 - 230000034659 glycolysis Effects 0.000 description 1
 - 230000002414 glycolytic effect Effects 0.000 description 1
 - 239000008187 granular material Substances 0.000 description 1
 - 125000001188 haloalkyl group Chemical group 0.000 description 1
 - 229910052736 halogen Inorganic materials 0.000 description 1
 - 239000011121 hardwood Substances 0.000 description 1
 - 239000001307 helium Substances 0.000 description 1
 - 229910052734 helium Inorganic materials 0.000 description 1
 - SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
 - 230000006801 homologous recombination Effects 0.000 description 1
 - 238000002744 homologous recombination Methods 0.000 description 1
 - 150000002431 hydrogen Chemical class 0.000 description 1
 - 239000001257 hydrogen Substances 0.000 description 1
 - 229910052739 hydrogen Inorganic materials 0.000 description 1
 - XVDFMHARQUBJRE-UHFFFAOYSA-N hydron;n-methyl-2-pyridin-2-ylethanamine;dichloride Chemical compound Cl.Cl.CNCCC1=CC=CC=N1 XVDFMHARQUBJRE-UHFFFAOYSA-N 0.000 description 1
 - 239000003752 hydrotrope Substances 0.000 description 1
 - 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
 - 238000011534 incubation Methods 0.000 description 1
 - 238000011090 industrial biotechnology method and process Methods 0.000 description 1
 - 230000002757 inflammatory effect Effects 0.000 description 1
 - 239000003112 inhibitor Substances 0.000 description 1
 - 230000002401 inhibitory effect Effects 0.000 description 1
 - 229910052500 inorganic mineral Inorganic materials 0.000 description 1
 - 229910017053 inorganic salt Inorganic materials 0.000 description 1
 - 230000010354 integration Effects 0.000 description 1
 - 238000007918 intramuscular administration Methods 0.000 description 1
 - 238000007912 intraperitoneal administration Methods 0.000 description 1
 - 238000007913 intrathecal administration Methods 0.000 description 1
 - 238000001990 intravenous administration Methods 0.000 description 1
 - 239000001573 invertase Substances 0.000 description 1
 - 235000011073 invertase Nutrition 0.000 description 1
 - JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
 - 229960000310 isoleucine Drugs 0.000 description 1
 - AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
 - YYVJAABUJYRQJO-UHFFFAOYSA-N isomyristic acid Chemical compound CC(C)CCCCCCCCCCC(O)=O YYVJAABUJYRQJO-UHFFFAOYSA-N 0.000 description 1
 - 150000002576 ketones Chemical class 0.000 description 1
 - 229940039696 lactobacillus Drugs 0.000 description 1
 - 238000011031 large-scale manufacturing process Methods 0.000 description 1
 - 101150026107 ldh1 gene Proteins 0.000 description 1
 - 101150041530 ldha gene Proteins 0.000 description 1
 - 239000010985 leather Substances 0.000 description 1
 - 230000003902 lesion Effects 0.000 description 1
 - 239000006028 limestone Substances 0.000 description 1
 - 230000000670 limiting effect Effects 0.000 description 1
 - 238000001638 lipofection Methods 0.000 description 1
 - 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
 - 230000001050 lubricating effect Effects 0.000 description 1
 - 238000012423 maintenance Methods 0.000 description 1
 - 238000001819 mass spectrum Methods 0.000 description 1
 - 238000005259 measurement Methods 0.000 description 1
 - 230000007246 mechanism Effects 0.000 description 1
 - 230000001404 mediated effect Effects 0.000 description 1
 - 239000013028 medium composition Substances 0.000 description 1
 - 229910052751 metal Inorganic materials 0.000 description 1
 - 239000002184 metal Substances 0.000 description 1
 - 150000002742 methionines Chemical class 0.000 description 1
 - 229920000609 methyl cellulose Polymers 0.000 description 1
 - 239000001923 methylcellulose Substances 0.000 description 1
 - 239000011707 mineral Substances 0.000 description 1
 - 238000010369 molecular cloning Methods 0.000 description 1
 - 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
 - 238000002703 mutagenesis Methods 0.000 description 1
 - 231100000350 mutagenesis Toxicity 0.000 description 1
 - 230000035772 mutation Effects 0.000 description 1
 - 208000015122 neurodegenerative disease Diseases 0.000 description 1
 - 230000003961 neuronal insult Effects 0.000 description 1
 - 230000002981 neuropathic effect Effects 0.000 description 1
 - QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
 - 239000002736 nonionic surfactant Substances 0.000 description 1
 - 229920001542 oligosaccharide Polymers 0.000 description 1
 - 150000002482 oligosaccharides Chemical class 0.000 description 1
 - 235000021354 omega 7 monounsaturated fatty acids Nutrition 0.000 description 1
 - 210000003463 organelle Anatomy 0.000 description 1
 - 150000007524 organic acids Chemical class 0.000 description 1
 - 235000005985 organic acids Nutrition 0.000 description 1
 - 238000006053 organic reaction Methods 0.000 description 1
 - 238000012261 overproduction Methods 0.000 description 1
 - 235000006408 oxalic acid Nutrition 0.000 description 1
 - 150000002913 oxalic acids Chemical class 0.000 description 1
 - 125000004430 oxygen atom Chemical group O* 0.000 description 1
 - 239000006072 paste Substances 0.000 description 1
 - 229920001277 pectin Polymers 0.000 description 1
 - 239000001814 pectin Substances 0.000 description 1
 - 235000010987 pectin Nutrition 0.000 description 1
 - 210000001428 peripheral nervous system Anatomy 0.000 description 1
 - 239000000546 pharmaceutical excipient Substances 0.000 description 1
 - 239000012071 phase Substances 0.000 description 1
 - COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
 - 102000030592 phosphoserine aminotransferase Human genes 0.000 description 1
 - 108010088694 phosphoserine aminotransferase Proteins 0.000 description 1
 - 230000029553 photosynthesis Effects 0.000 description 1
 - 238000010672 photosynthesis Methods 0.000 description 1
 - 230000001766 physiological effect Effects 0.000 description 1
 - 230000035790 physiological processes and functions Effects 0.000 description 1
 - 239000000049 pigment Substances 0.000 description 1
 - 239000004033 plastic Substances 0.000 description 1
 - 229920003023 plastic Polymers 0.000 description 1
 - 230000008488 polyadenylation Effects 0.000 description 1
 - 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
 - 101150043515 pps gene Proteins 0.000 description 1
 - 238000012545 processing Methods 0.000 description 1
 - 230000018612 quorum sensing Effects 0.000 description 1
 - 230000005855 radiation Effects 0.000 description 1
 - 230000002285 radioactive effect Effects 0.000 description 1
 - 230000002829 reductive effect Effects 0.000 description 1
 - 238000007670 refining Methods 0.000 description 1
 - 230000004044 response Effects 0.000 description 1
 - 206010039073 rheumatoid arthritis Diseases 0.000 description 1
 - 239000002336 ribonucleotide Substances 0.000 description 1
 - 125000002652 ribonucleotide group Chemical group 0.000 description 1
 - 108020000318 saccharopine dehydrogenase Proteins 0.000 description 1
 - 150000004671 saturated fatty acids Chemical class 0.000 description 1
 - 238000007789 sealing Methods 0.000 description 1
 - 230000028327 secretion Effects 0.000 description 1
 - 238000012163 sequencing technique Methods 0.000 description 1
 - 101150003830 serC gene Proteins 0.000 description 1
 - 239000010865 sewage Substances 0.000 description 1
 - 230000011664 signaling Effects 0.000 description 1
 - 239000004460 silage Substances 0.000 description 1
 - 229910052709 silver Inorganic materials 0.000 description 1
 - 239000004332 silver Substances 0.000 description 1
 - 239000000779 smoke Substances 0.000 description 1
 - 239000000344 soap Substances 0.000 description 1
 - 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
 - 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
 - 229910052938 sodium sulfate Inorganic materials 0.000 description 1
 - 235000011152 sodium sulphate Nutrition 0.000 description 1
 - 239000008247 solid mixture Substances 0.000 description 1
 - 101150038942 speA gene Proteins 0.000 description 1
 - UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
 - 229960000268 spectinomycin Drugs 0.000 description 1
 - 150000003408 sphingolipids Chemical class 0.000 description 1
 - 239000003381 stabilizer Substances 0.000 description 1
 - 230000000087 stabilizing effect Effects 0.000 description 1
 - 239000010902 straw Substances 0.000 description 1
 - 239000006190 sub-lingual tablet Substances 0.000 description 1
 - 238000007920 subcutaneous administration Methods 0.000 description 1
 - 229940098466 sublingual tablet Drugs 0.000 description 1
 - 125000005017 substituted alkenyl group Chemical group 0.000 description 1
 - KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
 - 235000000346 sugar Nutrition 0.000 description 1
 - 150000008163 sugars Chemical class 0.000 description 1
 - 125000004434 sulfur atom Chemical group 0.000 description 1
 - 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
 - 230000000475 sunscreen effect Effects 0.000 description 1
 - 239000000516 sunscreening agent Substances 0.000 description 1
 - 238000001356 surgical procedure Methods 0.000 description 1
 - 239000000375 suspending agent Substances 0.000 description 1
 - 230000002194 synthesizing effect Effects 0.000 description 1
 - 230000008685 targeting Effects 0.000 description 1
 - 238000002560 therapeutic procedure Methods 0.000 description 1
 - 125000005309 thioalkoxy group Chemical group 0.000 description 1
 - 230000000699 topical effect Effects 0.000 description 1
 - 238000013518 transcription Methods 0.000 description 1
 - 230000035897 transcription Effects 0.000 description 1
 - 238000012546 transfer Methods 0.000 description 1
 - 230000001131 transforming effect Effects 0.000 description 1
 - 230000017105 transposition Effects 0.000 description 1
 - 230000009529 traumatic brain injury Effects 0.000 description 1
 - QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
 - 210000004881 tumor cell Anatomy 0.000 description 1
 - RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
 - OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
 - 101150115617 umuC gene Proteins 0.000 description 1
 - 241001300301 uncultured bacterium Species 0.000 description 1
 - 101150004840 uspA gene Proteins 0.000 description 1
 - 239000004474 valine Substances 0.000 description 1
 - 239000003981 vehicle Substances 0.000 description 1
 - 239000004034 viscosity adjusting agent Substances 0.000 description 1
 - 239000011782 vitamin Substances 0.000 description 1
 - 235000013343 vitamin Nutrition 0.000 description 1
 - 229940088594 vitamin Drugs 0.000 description 1
 - 229930003231 vitamin Natural products 0.000 description 1
 - 238000001262 western blot Methods 0.000 description 1
 - 229920001221 xylan Polymers 0.000 description 1
 - 150000004823 xylans Chemical class 0.000 description 1
 
Images
Classifications
- 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
 - C12N15/09—Recombinant DNA-technology
 - C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
 - C12P13/00—Preparation of nitrogen-containing organic compounds
 - C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
 - C12N15/09—Recombinant DNA-technology
 - C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
 - C12N15/70—Vectors or expression systems specially adapted for E. coli
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
 - C12N15/09—Recombinant DNA-technology
 - C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
 - C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
 - C12N15/09—Recombinant DNA-technology
 - C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
 - C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
 - C12N9/10—Transferases (2.)
 - C12N9/1025—Acyltransferases (2.3)
 - C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
 - C12N9/14—Hydrolases (3)
 - C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
 - C12N9/14—Hydrolases (3)
 - C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
 - C12N9/18—Carboxylic ester hydrolases (3.1.1)
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12Y—ENZYMES
 - C12Y203/00—Acyltransferases (2.3)
 - C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
 - C12Y203/01086—Fatty-acyl-CoA synthase (2.3.1.86)
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12Y—ENZYMES
 - C12Y301/00—Hydrolases acting on ester bonds (3.1)
 - C12Y301/01—Carboxylic ester hydrolases (3.1.1)
 - C12Y301/01005—Lysophospholipase (3.1.1.5)
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12Y—ENZYMES
 - C12Y301/00—Hydrolases acting on ester bonds (3.1)
 - C12Y301/02—Thioester hydrolases (3.1.2)
 - C12Y301/02014—Oleoyl-[acyl-carrier-protein] hydrolase (3.1.2.14), i.e. ACP-thioesterase
 
 - 
        
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
 - Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
 - Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
 - Y02P20/00—Technologies relating to chemical industry
 - Y02P20/50—Improvements relating to the production of bulk chemicals
 - Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
 
 
Landscapes
- Chemical & Material Sciences (AREA)
 - Health & Medical Sciences (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Organic Chemistry (AREA)
 - Genetics & Genomics (AREA)
 - Engineering & Computer Science (AREA)
 - Wood Science & Technology (AREA)
 - Zoology (AREA)
 - Bioinformatics & Cheminformatics (AREA)
 - General Engineering & Computer Science (AREA)
 - General Health & Medical Sciences (AREA)
 - Biochemistry (AREA)
 - Biotechnology (AREA)
 - Biomedical Technology (AREA)
 - Microbiology (AREA)
 - Molecular Biology (AREA)
 - Medicinal Chemistry (AREA)
 - Physics & Mathematics (AREA)
 - Biophysics (AREA)
 - Plant Pathology (AREA)
 - Chemical Kinetics & Catalysis (AREA)
 - General Chemical & Material Sciences (AREA)
 - Preparation Of Compounds By Using Micro-Organisms (AREA)
 - Micro-Organisms Or Cultivation Processes Thereof (AREA)
 - Enzymes And Modification Thereof (AREA)
 
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| BR122019025755-8A BR122019025755B1 (pt) | 2012-04-13 | 2013-03-12 | Escherichia coli recombinante e método para produção de uma amida graxa | 
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US201261623711P | 2012-04-13 | 2012-04-13 | |
| US61/623,711 | 2012-04-13 | ||
| PCT/US2013/030502 WO2013154721A1 (en) | 2012-04-13 | 2013-03-12 | Microbial production of alkanolamides and amidoamines and uses thereof | 
Publications (2)
| Publication Number | Publication Date | 
|---|---|
| BR112014025519A2 BR112014025519A2 (OSRAM) | 2017-08-15 | 
| BR112014025519B1 true BR112014025519B1 (pt) | 2022-01-11 | 
Family
ID=47913634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| BR112014025519-9A BR112014025519B1 (pt) | 2012-04-13 | 2013-03-12 | Escherichia coli recombinante e método para produção de uma amida graxa | 
Country Status (13)
| Country | Link | 
|---|---|
| US (3) | US9683247B2 (OSRAM) | 
| EP (2) | EP4170026A1 (OSRAM) | 
| JP (1) | JP6251241B2 (OSRAM) | 
| KR (3) | KR102278343B1 (OSRAM) | 
| CN (3) | CN104379735A (OSRAM) | 
| AU (1) | AU2013246405B2 (OSRAM) | 
| BR (1) | BR112014025519B1 (OSRAM) | 
| CA (2) | CA2870257C (OSRAM) | 
| CO (1) | CO7200250A2 (OSRAM) | 
| IN (1) | IN2014DN09217A (OSRAM) | 
| MX (2) | MX354883B (OSRAM) | 
| MY (1) | MY167227A (OSRAM) | 
| WO (1) | WO2013154721A1 (OSRAM) | 
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| CN104379735A (zh) | 2012-04-13 | 2015-02-25 | Reg生命科学有限责任公司 | 烷醇酰胺及酰胺胺的微生物生产及其用途 | 
| EP3647430B1 (en) * | 2013-12-05 | 2022-10-26 | Genomatica, Inc. | Microbial production of fatty amines | 
| CN105884643B (zh) * | 2016-05-12 | 2018-03-27 | 浙江海正药业股份有限公司 | 一种不饱和脂肪酸酰胺类化合物及其制备方法和用途 | 
| CN107022513A (zh) * | 2017-03-17 | 2017-08-08 | 河北美邦工程科技股份有限公司 | 一种重组大肠杆菌菌株生产长链二元酸的方法 | 
| CN109082387B (zh) * | 2018-03-14 | 2022-03-18 | 重庆理工大学 | 一种可低温去除高氨氮的异养硝化-好氧反硝化复合菌剂及其应用 | 
| EP3844269A4 (en) | 2018-08-31 | 2022-07-27 | Genomatica, Inc. | PRODUCTION OF NON-NATIVE MONO-UNSATURATED FATTY ACIDS IN BACTERIA | 
| CA3130763A1 (en) | 2019-02-25 | 2020-09-03 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors | 
| US11441162B2 (en) * | 2019-03-08 | 2022-09-13 | Massachusetts Institute Of Technology | Human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides | 
| CN110272839B (zh) * | 2019-05-08 | 2020-10-30 | 江南大学 | 一株不动杆菌及其在生产手性3-环己烯-1-甲酸中的应用 | 
| GB202019175D0 (en) * | 2020-12-04 | 2021-01-20 | Univ Tartu | Biosynthesis method | 
| US11286467B1 (en) | 2020-12-14 | 2022-03-29 | United Arab Emirates University | System and method for production of fatty acid ethanolamides | 
| US20250207159A1 (en) | 2022-03-16 | 2025-06-26 | Genomatica, Inc. | Microorganisms And Methods For Production Of Fatty Acid Derivatives With Reduced Levels Of Byproducts | 
| WO2023178193A1 (en) | 2022-03-16 | 2023-09-21 | Genomatica, Inc. | Acyl-acp thioesterase variants and uses thereof | 
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US5028539A (en) | 1988-08-31 | 1991-07-02 | The University Of Florida | Ethanol production using engineered mutant E. coli | 
| US5482846A (en) | 1988-08-31 | 1996-01-09 | University Of Florida | Ethanol production in Gram-positive microbes | 
| US5000000A (en) | 1988-08-31 | 1991-03-19 | University Of Florida | Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes | 
| US5424202A (en) | 1988-08-31 | 1995-06-13 | The University Of Florida | Ethanol production by recombinant hosts | 
| US5602030A (en) | 1994-03-28 | 1997-02-11 | University Of Florida Research Foundation | Recombinant glucose uptake system | 
| US6428767B1 (en) | 1995-05-12 | 2002-08-06 | E. I. Du Pont De Nemours And Company | Method for identifying the source of carbon in 1,3-propanediol | 
| US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same | 
| MA24136A1 (fr) | 1996-04-16 | 1997-12-31 | Procter & Gamble | Fabrication d'agents de surface . | 
| US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids | 
| DE19731881C1 (de) | 1997-07-24 | 1998-10-22 | Henkel Kgaa | Verwendung von Elektrolytgemischen als Sequestriermittel | 
| JP4817495B2 (ja) | 1998-05-29 | 2011-11-16 | ニューロサイエンシーズ・リサーチ・ファウンデーション・インコーポレーテッド | 外因性カンナビノイドでの痛みの制御 | 
| WO2008100251A1 (en) | 2007-02-13 | 2008-08-21 | Ls9, Inc. | Modified microorganism uses therefor | 
| US20100242345A1 (en) | 2006-05-19 | 2010-09-30 | LS9, Inc | Production of fatty acids & derivatives thereof | 
| CA2650773C (en) | 2006-05-19 | 2014-12-02 | Jay D. Keasling | Microorganisms transformed with acetyl-coa carboxylase and wax synthase for production of fatty acid derivatives | 
| CN101490241A (zh) * | 2006-05-19 | 2009-07-22 | Ls9公司 | 脂肪酸及其衍生物的制备 | 
| BRPI0809345A2 (pt) | 2007-03-28 | 2014-10-07 | Ls9 Inc | Células recombinantes, composições produzidas por estas, métodos para produzir derivados de ácidos graxos em uma célula recombinante, para aumentar a produção de derivados de ácidos graxos em uma célula recombinante, construto recombinante, vetores, métodos para aumentar a produção de derivados de ácidos graxos em uma célula hospedeira de produção, para produzir derivados de ácidos graxos, derivados de ácidos graxos, composições de biocombustível. | 
| US8048654B2 (en) * | 2010-06-09 | 2011-11-01 | Joule Unlimited Technologies, Inc. | Methods and compositions for the recombinant biosynthesis of fatty acids and esters | 
| CA3038491A1 (en) | 2008-10-07 | 2010-04-15 | REG Life Sciences, LLC | Bacterial host cells engineered to express a carboxylic acid reductase and a thioesterase | 
| CA2740037C (en) | 2008-10-28 | 2019-06-18 | Ls9, Inc. | Methods for producing a fatty alcohol in a host cell | 
| EP2382285B1 (en) | 2008-12-23 | 2019-05-01 | REG Life Sciences, LLC | Methods and compositions related to thioesterase enzymes | 
| CA2758298A1 (en) | 2009-04-10 | 2010-10-14 | Ls9, Inc. | Production of commercial biodiesel from genetically modified microorganisms | 
| CA3056664A1 (en) | 2009-09-25 | 2011-03-31 | Alfred Gaertner | Production of fatty acid derivatives in recombinant bacterial cells expressing an ester synthase variant | 
| US8859259B2 (en) | 2010-02-14 | 2014-10-14 | Ls9, Inc. | Surfactant and cleaning compositions comprising microbially produced branched fatty alcohols | 
| CN104379735A (zh) | 2012-04-13 | 2015-02-25 | Reg生命科学有限责任公司 | 烷醇酰胺及酰胺胺的微生物生产及其用途 | 
- 
        2013
        
- 2013-03-12 CN CN201380026545.3A patent/CN104379735A/zh active Pending
 - 2013-03-12 IN IN9217DEN2014 patent/IN2014DN09217A/en unknown
 - 2013-03-12 CA CA2870257A patent/CA2870257C/en active Active
 - 2013-03-12 MY MYPI2014002870A patent/MY167227A/en unknown
 - 2013-03-12 WO PCT/US2013/030502 patent/WO2013154721A1/en active Application Filing
 - 2013-03-12 CN CN202011494386.8A patent/CN112522170A/zh active Pending
 - 2013-03-12 BR BR112014025519-9A patent/BR112014025519B1/pt not_active IP Right Cessation
 - 2013-03-12 MX MX2014012350A patent/MX354883B/es active IP Right Grant
 - 2013-03-12 MX MX2018003178A patent/MX391947B/es unknown
 - 2013-03-12 US US14/394,070 patent/US9683247B2/en active Active
 - 2013-03-12 JP JP2015505727A patent/JP6251241B2/ja not_active Expired - Fee Related
 - 2013-03-12 KR KR1020207024620A patent/KR102278343B1/ko not_active Expired - Fee Related
 - 2013-03-12 CN CN201810830455.4A patent/CN108949660A/zh active Pending
 - 2013-03-12 AU AU2013246405A patent/AU2013246405B2/en not_active Ceased
 - 2013-03-12 EP EP22197291.2A patent/EP4170026A1/en active Pending
 - 2013-03-12 CA CA3081178A patent/CA3081178C/en active Active
 - 2013-03-12 EP EP13711261.1A patent/EP2836593A1/en not_active Withdrawn
 - 2013-03-12 KR KR1020147031804A patent/KR102190262B1/ko not_active Expired - Fee Related
 - 2013-03-12 KR KR1020217021746A patent/KR20210091353A/ko not_active Ceased
 
 - 
        2014
        
- 2014-11-12 CO CO14250335A patent/CO7200250A2/es unknown
 
 - 
        2017
        
- 2017-06-15 US US15/623,855 patent/US10392637B2/en active Active
 
 - 
        2019
        
- 2019-08-22 US US16/548,545 patent/US10975402B2/en active Active
 
 
Also Published As
| Publication number | Publication date | 
|---|---|
| JP6251241B2 (ja) | 2017-12-20 | 
| MX354883B (es) | 2018-03-23 | 
| CA2870257A1 (en) | 2013-10-17 | 
| CA2870257C (en) | 2020-07-28 | 
| US20200232001A1 (en) | 2020-07-23 | 
| AU2013246405B2 (en) | 2018-08-02 | 
| AU2013246405A1 (en) | 2014-10-30 | 
| KR20150031230A (ko) | 2015-03-23 | 
| KR102190262B1 (ko) | 2020-12-14 | 
| US10392637B2 (en) | 2019-08-27 | 
| US9683247B2 (en) | 2017-06-20 | 
| CN104379735A (zh) | 2015-02-25 | 
| KR20200105535A (ko) | 2020-09-07 | 
| CN108949660A (zh) | 2018-12-07 | 
| US20150079643A1 (en) | 2015-03-19 | 
| KR20210091353A (ko) | 2021-07-21 | 
| JP2015516808A (ja) | 2015-06-18 | 
| CA3081178C (en) | 2023-02-21 | 
| US10975402B2 (en) | 2021-04-13 | 
| IN2014DN09217A (OSRAM) | 2015-07-10 | 
| EP4170026A1 (en) | 2023-04-26 | 
| MX391947B (es) | 2025-03-21 | 
| CN112522170A (zh) | 2021-03-19 | 
| CA3081178A1 (en) | 2013-10-17 | 
| WO2013154721A1 (en) | 2013-10-17 | 
| EP2836593A1 (en) | 2015-02-18 | 
| BR112014025519A2 (OSRAM) | 2017-08-15 | 
| MY167227A (en) | 2018-08-14 | 
| CO7200250A2 (es) | 2015-02-27 | 
| US20170292120A1 (en) | 2017-10-12 | 
| KR102278343B1 (ko) | 2021-07-16 | 
| MX2014012350A (es) | 2015-06-04 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| US10975402B2 (en) | Microbial production of alkanolamides and amidoamines and uses thereof | |
| EP2756090B1 (en) | Production of odd chain fatty acid derivatives in recombinant microbial cells | |
| AU2017200596B2 (en) | Acyl-ACP reductase with improved properties | |
| ES2808287T3 (es) | Métodos y composiciones para la producción mejorada de ácidos grasos y derivados de los mismos | |
| AU2014360086B2 (en) | Microbial production of fatty amines | |
| ES2693753T3 (es) | Producción de ácidos grasos de cadena ramificada y derivados de los mismos en células microbianas recombinantes | |
| EP3087179A1 (en) | Omega-hydroxylase-related fusion polypeptides with improved properties | |
| JP6837089B2 (ja) | 改善されたアセチル−CoAカルボキシラーゼ変種 | |
| BR122019025755B1 (pt) | Escherichia coli recombinante e método para produção de uma amida graxa | |
| BR122017000832A2 (pt) | polipeptídeo da variante acil-acp redutase (aar), célula hospedeira recombinante, cultura celular, método de produção de composição de álcool graxo tendo aumento do título | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B25A | Requested transfer of rights approved | 
             Owner name: GENOMATICA, INC. (US)  | 
        |
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | 
             Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/03/2013, OBSERVADAS AS CONDICOES LEGAIS.  | 
        |
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time | 
             Free format text: REFERENTE A 11A ANUIDADE.  | 
        |
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) | 
             Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2765 DE 02-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.  |